Rosalind P. Candelaria, M.D.

Peer-Reviewed Articles

1. Xu Z, Zhou Z, Son JB, Feng H, Adrada BE, Moseley TW, Candelaria RP, Guirguis M, Patel MM, Whitman GJ, Leung J WT, Le-Petross HT, Mohamed RM, Panthi B, Lane DL, Chen H, Wei P, Tripathy D, Litton JK, Valero V, Huo L, Hunt KK, Korkut A, Thompson A, Yang W, Yam C, Rauch GM, Ma J. Deep learning models based on pretreatment MRI and clinicopathological data to predict response to neoadjuvant systemic therapy in triple-negative breast cancer. Cancers 17(6), 2025. e-Pub 2025.
2. Huang ML, Lane DL, Chang Sen LQ, Candelaria RP, Kuerer HM, Hunt KK, Akay C, Lim B, Shaitelman S, Hwang RF, Chen H, Katta R, Santiago L. Defining breast cryoablation treatment success: a guide for the curative and palliative treatment of breast cancer. Acad Radiol 31(12):4759-4771, 2024. e-Pub 2024. PMID: 39107186.
3. Wanis KN, Goetz L, So A, Glencer AC, Sun SX, Teshome M, Resetkova E, Hwang RF, Hunt KK, Candelaria RP, Huo L, Singh P. The prevalence of sentinel lymph node positivity and implications for the utility of frozen section diagnosis following neoadjuvant systemic therapy in patients with clinically node-negative HER2-positive or triple-negative breast cancer. Ann Surg Oncol 31(11):7339-7346, 2024. e-Pub 2024. PMID: 39048903.
4. Yam, C, Patel, MM, Hill, H, Sun, R, Bassett Jr, R, Kong, EK, Damodaran, S, Koenig, KB, Abouharb, S, Saleem, S, Bisen, AK, Murthy, RK, Ramirez, DL, Rauch, GM, Adrada, BE, Candelaria, RP, Wang, X, Mittendorf, EA, Thompson, A, White, JB, Ravenberg, EE, Clayborn, A, Ding, Q, Booser, DJ, Oke, OC, Brewster, A, Hortobagyi, GN, Ibrahim, NK, Litton, J, Valero, V, Arun, BK, Tripathy, D, Chang, J, Chen, K, Korkut, A, Moulder, S, Huo, L, Lim, B, Ueno, NT. Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer. Cancer Research Communications 4(10):2823-2834, 2024. e-Pub 2024. PMID: 39356138.
5. Mohamed, RM, Panthi, B, Adrada, BE, Boge, M, Candelaria, RP, Chen, H, Guirguis, MS, Hunt, KK, Huo, L, Hwang, K, Korkut, A, Litton, JK, Moseley, T, Pashapoor, S, Patel, MM, Reed, BJ, Scoggins, ME, Son, JB, Thompson, A, Tripathy, D, Valero, V, Wei, P, White, JB, Whitman, GJ, Xu, Z, Yang, W, Yam, C, Ma, J, Rauch, GM. Multiparametric MRI–based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Scientific reports 14(1), 2024. e-Pub 2024. PMID: 38992094.
6. Lim, B, Seth, S, Yam, C, Huo, L, Fujii, T, Lee, J, Bassett Jr, R, Nasser, S, Ravenberg, L, White, JB, Clayborn, A, Guerra, G, Litton, J, Damodaran, S, Layman, RM, Valero, V, Tripathy, D, Lewis, MT, Dobrolecki, LE, Lei, JT, Candelaria, RP, Arun, BK, Rauch, GM, Zhao, L, Zhang, J, Ding, Q, Symmans, WF, Chang, J, Thompson, A, Moulder, S, Ueno, NT. Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC. Cell Reports Medicine 5(6), 2024. e-Pub 2024. PMID: 38838676.
7. Lim B, Seth S, Yam C, Huo L, Fujii T, Candelaria R, Lee J. “Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor–enriched TNBC: trial results and insights into “ARness”. Cell Rep Med 5(6). e-Pub 2024. PMID: 38838676.
8. Musall BC, Rauch DE, Mohamed RMM, Panthi B, Boge M, Candelaria RP, Chen H, Guirguis MS, Hunt KK, Huo L, Hwang KP, Korkut A, Litton JK, Moseley TW, Pashapoor S, Patel MM, Reed BJ, Scoggins ME, Son JB, Tripathy D, Valero V, Wei P, White JB, Whitman GJ, Xu Z, Yang WT, Yam C, Adrada BE, Ma J. Diffusion tensor imaging for characterizing changes in triple-negative breast cancer during neoadjuvant systemic therapy. J Magn Reson Imaging 60(4):1367-1376, 2024. e-Pub 2024. PMID: 38294179.
9. Zhou, Z, Adrada, BE, Candelaria, RP, Elshafeey, N, Boge, M, Mohamed, RM, Pashapoor, S, Sun, J, Xu, Z, Panthi, B, Son, JB, Guirguis, MS, Patel, MM, Whitman, GJ, Moseley, T, Scoggins, ME, White, JB, Litton, J, Valero, V, Hunt, KK, Tripathy, D, Yang, WT, Wei, P, Yam, C, Pagel, MD, Rauch, GM, Ma, J. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Scientific reports 13(1), 2023. e-Pub 2023. PMID: 36670144.
10. Nia E, Patel M, Kapoor M, Guirguis M, Perez F, Bassett R, Candelaria R. Comparing the performance of full-field digital mammography and digital breast tomosynthesis in the post treatment surveillance of patients with a history of breast cancer: a retrospective study. Radiography (Lond) 29(6):975-979, 2023. e-Pub 2023. PMID: 37572571.
11. Xu, Z, Rauch, DE, Mohamed, RM, Pashapoor, S, Zhou, Z, Panthi, B, Son, JB, Hwang, K, Musall, BC, Adrada, BE, Candelaria, RP, Leung, J, Le-Petross, H, Lane, DL, Perez, F, White, JB, Clayborn, A, Reed, BJ, Chen, H, Sun, J, Wei, P, Thompson, A, Korkut, A, Huo, L, Hunt, KK, Litton, J, Valero, V, Tripathy, D, Yang, W, Yam, C, Ma, J. Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer. Cancers 15(19), 2023. e-Pub 2023. PMID: 37835523.
12. Panthi B, Mohamed RM, Adrada B, Candelaria R, Guirguis MS, Yang W, Boge M, Patel M, Elshafeey N, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HTC, Leung J, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley T, Perez F, White J, Ravenberg E, Clayborn A, Pagel M, Chen H, Sun J, Wei P, Thompson AM, Moulder S, Korkut A, Huo L, Hunt KK, Litton JK, Valero V, Tripathy D, Yam C, Ma J, Rauch G. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Front. Oncol 13, 2023. e-Pub 2023. PMID: 37941561.
13. Johnson HM, Lin H, Shen Y, Diego EJ, Krishnamurthy S, Yang WT, Smith BD, Valero V, Lucci A, Sun SX, Shaitelman SF, Mitchell MP, Boughey JC, White RL, Rauch GM, Kuerer HM, Moseley TW, Leung JW, Huang M, Candelaria RP, et al. Patient-reported outcomes of omission of breast surgery following neoadjuvant systemic therapy a nonrandomized clinical trial. JAMA Netw Open, 2023. e-Pub 2023. PMID: 37707811.
14. Abuhadra, NK, Sun, R, Yam, C, Rauch, GM, Ding, Q, Lim, B, Thompson, A, Mittendorf, EA, Adrada, BE, Damodaran, S, Virani, K, White, JB, Ravenberg, EE, Sun, J, Choi, J, Candelaria, RP, Arun, BK, Ueno, NT, Santiago, L, Saleem, S, Abouharb, S, Murthy, RK, Ibrahim, NK, Sahin, AA, Valero, V, Symmans, WF, Litton, J, Tripathy, D, Moulder, S, Huo, L. Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective Trial. Cancers 15(13), 2023. e-Pub 2023. PMID: 37444385.
15. Hwang, K, Elshafeey, N, Kotrotsou, A, Chen, H, Son, JB, Boge, M, Mohamed, RM, Abdelhafez, AH, Adrada, BE, Panthi, B, Sun, J, Musall, BC, Zhang, S, Candelaria, RP, White, JB, Ravenberg, EE, Tripathy, D, Yam, C, Litton, J, Huo, L, Thompson, A, Wei, P, Yang, WT, Pagel, MD, Ma, J, Rauch, GM. A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer. Radiology: Imaging Cancer 5(4), 2023. e-Pub 2023. PMID: 37505106.
16. Zhou, Z, Adrada, BE, Candelaria, RP, Elshafeey, N, Boge, M, Mohamed, RM, Pashapoor, S, Sun, J, Xu, Z, Panthi, B, Son, JB, Guirguis, MS, Patel, MM, Whitman, GJ, Moseley, T, Scoggins, ME, White, JB, Litton, J, Valero, V, Hunt, KK, Tripathy, D, Yang, W, Wei, P, Yam, C, Pagel, MD, Rauch, GM, Ma, J. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2023:1-4, 2023. e-Pub 2023. PMID: 38083160.
17. Abuhadra N, Sun R, Bassett RL, Huo L, Chang JT, Teshome M, Clayborn AR, White JB, Ravenberg EE, Adrada BE, Candelaria RP, Yang W, Ding Q, Symmans WF, Arun B, Damodaran S, Koenig KB, Layman RM, Lim B, Litton JK, Thompson A, Ueno NT, Piwnica-Worms H, Hortobagyi GN, Valero V, Tripathy D, Rauch GM, Moulder S, Yam C. Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: A phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy. Invest New Drugs 41(3):391-401, 2023. e-Pub 2023. PMID: 37043123.
18. Abuhadra N, Sun R, Yam C, Rauch GM, Ding Q, Lim B, Thompson A, Mittendorf EA, Adrada B, Damodaran S, Virani K, White J, Ravenberg E, Sun J, Choi J, Candelaria R, Arun B, Ueno NT, Santiago L, Saleem S, Abouharb S, Murthy RK, Ibrahim N, Sahin A, Valero V, Symmans WF, Litton JK, Tripathy D, Moulder S, Huo\L. Predictive role of baseline stromal tumor-infiltrating lymphocytes and Ki-67 for pathologic complete response in an early-stage triple-negative breast cancer prospective trial. Cancers 15, 2023. e-Pub 2023.
19. Yam C, Mittendorf EA, Garber HR, Sun R, Damodaran S, Murthy RK, Ramirez D, Karuturi M, Layman R, Ibrahim N, Rauch GM, Adrada BE, Candelaria RP, White JB, Ravenberg E, Clayborn A, Ding QQ, Symmans WF, Prabhakaran S, Thompson AM, Valero V, Tripathy D, Huo L, Moulder S, Litton JK. A phase II study of neoadjuvant atezolizumab and nab-paclitaxel in patients with anthracycline-resistant early-stage triple-negative breast cancer. Breast Cancer Research and Treatment 199(3):457-469, 2023. e-Pub 2023. PMID: 37061619.
20. Panthi, B, Adrada, BE, Candelaria, RP, Guirguis, MS, Yam, C, Boge, M, Chen, H, Hunt, KK, Huo, L, Hwang, K, Korkut, A, Lane, DL, Le-Petross, H, Leung, J, Litton, J, Mohamed, RM, Musall, BC, Pashapoor, S, Patel, MM, Perez, F, Son, JB, Thompson, A, Valero, V, Wei, P, White, JB, Xu, Z, Pinsky, L, Tripathy, D, Yang, WT, Ma, J, Rauch, GM. Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI. Cancers 15(4), 2023. e-Pub 2023. PMID: 36831368.
21. Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yam C, Boge M, Chen H, Hunt KK, Huo L, Hwang KP, Korkut A, Lane DL, Le-Petross HC, Leung JWT, Litton JK, Mohamed RM, Musall BC, Pashapoor S, Patel MM, Perez F, Son JB, Thompson A, Valero V, Wei P, White J, Xu Z, Pinsky L, Tripathy D, Yang W, Ma J, Rauch GM. Assessment of response to neoadjuvant systemic treatment in triple-negative breast cancer using functional tumor volumes from longitudinal dynamic contrast-enhanced MRI. Cancers 15(4), 2023. e-Pub 2023.
22. Panthi, B, Mohamed, RM, Adrada, BE, Boge, M, Candelaria, RP, Chen, H, Hunt, KK, Huo, L, Hwang, K, Korkut, A, Lane, DL, Le-Petross, H, Leung, J, Litton, J, Pashapoor, S, Perez, F, Son, JB, Sun, J, Thompson, A, Tripathy, D, Valero, V, Wei, P, White, JB, Xu, Z, Yang, W, Zhou, Z, Yam, C, Rauch, GM, Ma, J. Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Frontiers in Oncology 13, 2023. e-Pub 2023. PMID: 37941561.
23. Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu Z, Panthi B, Son JB, Guirguis MS, Patel MM, Whitman GJ, Moseley TW, Scoggins ME, White JB, Litton JK, Valero V, Hunt KK, Tripathy D, Yang W, Wei P, Yam C, Pagel MD, Rauch GM, Ma J. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Scientific Reports 13(1171), 2023. e-Pub 2023. PMID: 36670144.
24. Hwang KP, Elshafeey NA, Kotrotsou A, Chen H, Son JB, Boge M, Mohamed RM, Abdelhafez AH, Adrada BE, Panthi B, Sun J, Musall BC, Zhang S, Candelaria RP, White JB, Ravenberg EE, Tripathy D, Yam C, Litton JK, Huo L, Thompson AM, Wei P, Yang WT, Pagel MD, j M, Rauch GM. A radiomics model based on Synthetic MR acquisition for predicting neoadjuvant systemic treatment response in triple-negative breast cancer. Radiology: Imaging Cancer 5(4), 2023. e-Pub 2023.
25. Echeverria GV, Cai S, Tu Y, Shao J, Powell E, Redwood AB, Jiang Y, McCoy A, Rinkenbaugh AL, Lau R, Trevarton AJ, Fu C, Gould R, Ravenberg EE, Huo L, Candelaria R, Santiago L, Adrada BE, Lane DL, Rauch GM, Yang WT, White JB, Chang JT, Moulder SL, Symmans WF, Hilsenbeck SG, Piwnica-Worms H. Predictors of success in establishing orthotopic patient-derived xenograft models of triple negative breast cancer. NPJ Breast Cancer 9(1):2, 2023. e-Pub 2023. PMID: 36627285.
26. Chen H, Ding Q, Khazai L, Zhao L, Damodaran S, Litton JK, Rauch GM, Yam C, Chang JT, Seth S, Lim B, Thompson AM, Mittendorf EA, Adrada B, Virani K, White JB, Ravenberg E, Song X, Candelaria R, Arun B, Ueno NT, Santiago L, Saleem S, Abouharb S, Murthy RK, Ibrahim N, Routbort MJ, Sahin A, Valero V, Symmans WF, Tripathy D, Wang WL, Moulder S, Huo L. PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimens. Ther Adv Med Oncol 15:17588359231189422, 2023. e-Pub 2023. PMID: 37547448.
27. Kuerer HM, Smith BD, Krishnamurthy S, Yang WT, Valero V, Shen Y, Lin H, Lucci A, Boughey JC, White RL, Diego EJ, Rauch GM, Trials Group ERC. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial. Lancet Oncol 23(12):1517-1524, 2022. e-Pub 2022. PMID: 36306810.
28. Musall BC, Adrada BE, Candelaria RP, Mohamed RMM, Abdelhafez AH, Son JB, Sun J, Santiago L, Whitman GJ, Moseley TW, Scoggins ME, Mahmoud HS, White JB, Hwang KP, Elshafeey NA, Boge M, Zhang S, Litton JK, Valero V, Tripathy D, Thompson AM, Yam C, Wei P, Moulder SL, Pagel MD, Yang WT, Ma J, Rauch GM. Quantitative apparent diffusion coefficients from peritumoral regions as early predictors of response to neoadjuvant systemic therapy in triple-negative breast cancer. J Magn Reson Imaging 56(6):1901-1909, 2022. e-Pub 2022. PMID: 35499264.
29. Wu C, Jarrett AM, Zhou Z, Elshafeey N, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Huo L, White JB, Tripathy D, Valero V, Litton JK, Yam C, Son JB, Ma J, Rauch GM, Yankeelov TE. MRI-based digital models forecast patient-specific treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer. Cancer Res 82(18):3394-3404, 2022. e-Pub 2022. PMID: 35914239.
30. Yam C, Abuhadra N, Sun R, Adrada BE, Ding QQ, White JB, Ravenberg EE, Clayborn AR, Valero V, Tripathy D, Damodaran S, Arun BK, Litton JK, Ueno NT, Murthy RK, Lim B, Baez L, Li X, Buzdar AU, Hortobagyi GN, Thompson AM, Mittendorf EA, Rauch GM, Candelaria RP, Huo L, Moulder SL, Chang JT. Molecular characterization and prospective evaluation of pathological response and outcomes with neoadjuvant therapy in metaplastic triple-negative breast cancer. Clin Cancer Res 28(13):2878-2889, 2022. e-Pub 2022. PMID: 35507014.
31. Huang ML, Hess K, Ma J, Santiago L, Scoggins ME, Arribas E, Adrada BE, Le-Petross HT, Leung JWT, Yang W, Geiser W, Candelaria RP. Prospective comparison of synthesized mammography with DBT and full-field digital mammography with DBT uncovers recall disagreements that may impact cancer detection. Acad Radiol 29(7):1039-1045, 2022. e-Pub 2022. PMID: 34538550.
32. Candelaria RP, Adrada BE, Lane DL, Rauch GM, Moulder SL, Thompson AM, Bassett RL, Arribas EM, Le-Petross HT, Leung JWT, Spak DA, Ravenberg EE, White JB, Valero V, Yang WT. Midtreatment ultrasound descriptors as qualitative imaging biomarkers of pathologic complete response in patients with triple negative breast cancer. Ultrasound Med Biol 48(6):1010-1018, 2022. e-Pub 2022. PMID: 35300879.
33. Jimenez JE, Abdelhafez A, Mittendorf EA, Elshafeey N, Yung JP, Litton JK, Adrada BE, Candelaria RP, White J, Thompson AM, Huo L, Wei P, Tripathy D, Valero V, Yam C, Hazle JD, Moulder SL, Yang WT, Rauch GM. A model combining pretreatment MRI radiomic features and tumor-infiltrating lymphocytes to predict response to neoadjuvant systemic therapy in triple-negative breast cancer. Eur J Radiol 149:110220, 2022. e-Pub 2022. PMID: 35193025.
34. Abuhadra N, Sun R, Litton JK, Rauch GM, Yam C, Chang JT, Seth S, Bassett R, Lim B, Thompson AM, Mittendorf E, Adrada BE, Damodaran S, White J, Ravenberg E, Candelaria R, Arun B, Ueno NT, Santiago L, Saleem S, Abouharb S, Murthy RK, Ibrahim N, Sahin AA, Valero V, Symmans WF, Tripathy D, Moulder S, Huo L. Prognostic impact of high baseline stromal tumor-infiltrating lymphocytes in the absence of pathologic complete response in early-stage triple-negative breast cancer. Cancers (Basel) 14(5), 2022. e-Pub 2022. PMID: 35267631.
35. Candelaria RP, Spak DA, Rauch GM, Huo L, Bassett RL, Santiago L, Scoggins ME, Guirguis MS, Patel MM, Whitman GJ, Moulder SL, Thompson AM, Ravenberg EE, White JB, Abuhadra NK, Valero V, Litton J, Adrada BE, Yang WT. BI-RADS ultrasound lexicon descriptors and stromal tumor-infiltrating lymphocytes in triple-negative breast cancer. Acad Radiol 29 Suppl 1:S35-S41, 2022. e-Pub 2022. PMID: 34272161.
36. Irajizad E, Wu R, Vykoukal J, Murage E, Spencer R, Dennison JB, Moulder S, Ravenberg E, Lim B, Litton J, Tripathym D, Valero V, Damodaran S, Rauch GM, Adrada B, Candelaria R, White JB, Brewster A, Arun B, Long JP, Do KA, Hanash S, Fahrmann JF. Application of artificial intelligence to plasma metabolomics profiles to predict response to neoadjuvant chemotherapy in triple-negative breast cancer. Front Artif Intell 5:876100, 2022. e-Pub 2022. PMID: 36034598.
37. Adrada BE, Candelaria R, Moulder S, Thompson A, Wei P, Whitman GJ, Valero V, Litton JK, Santiago L, Scoggins ME, Moseley TW, White JB, Ravenberg EE, Yang WT, Rauch GM. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer 127(16):2880-2887, 2021. e-Pub 2021. PMID: 33878210.
38. Musall BC, Abdelhafez AH, Adrada BE, Candelaria RP, Mohamed RMM, Boge M, Le-Petross H, Arribas E, Lane DL, Spak DA, Leung JWT, Hwang KP, Son JB, Elshafeey NA, Mahmoud HS, Wei P, Sun J, Zhang S, White JB, Ravenberg EE, Litton JK, Damodaran S, Thompson AM, Moulder SL, Yang WT, Pagel MD, Rauch GM, Ma J. Functional tumor volume by fast dynamic contrast-enhanced MRI for predicting neoadjuvant systemic therapy response in triple-negative breast cancer. J Magn Reson Imaging 54(1):251-260, 2021. e-Pub 2021. PMID: 33586845.
39. Nia ES, Huang ML, Sun SX, Mitchell MP, Myatt JP, Candelaria RP. The mammographic appearance of the BioMonitor implantable loop recorder. Clin Imaging 73:28-30, 2021. e-Pub 2021. PMID: 33296770.
40. Guirguis MS, Adrada B, Santiago L, Candelaria R, Arribas E. Mimickers of breast malignancy: Imaging findings, pathologic concordance and clinical management. Insights Imaging 12(53), 2021. e-Pub 2021. PMID: 33877461.
41. Nia ES, Adrada BE, Whitman GJ, Candelaria RP, Krishnamurthy S, Bassett RL, M Arribas E. MRI features of pseudoangiomatous stromal hyperplasia with histopathological correlation. Breast J 27(3):242-247, 2021. e-Pub 2021. PMID: 33393706.
42. Bragg A, Candelaria R, Adrada B, Huang M, Rauch G, Santiago L, Scoggins M, Whitman G. Imaging of noncalcified ductal carcinoma in situ. J Clin Imaging Sci 11(34):34, 2021. e-Pub 2021. PMID: 34221643.
43. Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male mammary Paget disease: A tale of 2 contrasting cases. Am J Dermatopathol 42(12):981-985, 2020. e-Pub 2020. PMID: 33289978.
44. Scoggins ME, Arun BK, Candelaria RP, Dryden MJ, Wei W, Son JB, Ma J, Dogan BE. Should abbreviated breast MRI be compliant with American College of Radiology requirements for MRI accreditation?. Magn Reson Imaging 72:87-94, 2020. e-Pub 2020. PMID: 32622851.
45. Yalniz C, Meis JM, Wang WL, Huo L, Candelaria RP, Adrada BE, Lane D, Santiago L, Huang ML. Proliferative fasciitis mimicking sarcoma in the breast. Breast J 26(10):2072-2074, 2020. e-Pub 2020. PMID: 32854140.
46. Candelaria RP, Adrada BE, Hess K, Santiago L, Lane DL, Thompson AM, Moulder SL, Huang ML, Arribas EM, Rauch GM, Leung JWT, Symmans WF, Valero V, Ravenberg EE, White JB, Yang WT. Axillary ultrasound during neoadjuvant systemic therapy in triple-negative breast cancer patients. Eur J Radiol 130:109170, 2020. e-Pub 2020. PMID: 32777736.
47. Park KU, Weiss A, Rosso K, Yi M, Hunt K, Kuerer H, Hanson SE, Candelaria R, Tevis S, Thompson A. Use of mammographic measurements to predict complications after nipple-sparing mastectomy in BRCA mutation carriers. Ann Surg Oncol 27(2):367-372, 2020. e-Pub 2020. PMID: 31399819.
48. Candelaria RP, Adrada BE, Wei W, Thompson AM, Santiago L, Lane DL, Huang ML, Arribas EM, Rauch GM, Symmans WF, Gilcrease MZ, Huo L, Lim B, Ueno NT, Moulder SL, Yang WT. Imaging features of triple-negative breast cancers according to androgen receptor status. Eur J Radiol 114:167-174, 2019. e-Pub 2019. PMID: 31005169.
49. Speer ME, Huang ML, Dogan BE, Adrada BE, Candelaria RP, Hess KR, Hansakul P, Yang WT, Rauch GM. High risk breast lesions identified on MRI-guided vacuum assisted needle biopsy: Outcome of surgical excision and imaging follow-up. Br J Radiol 91(1090):20180300, 2018. e-Pub 2018. PMID: 29947265.
50. Rauch GM, Kuerer HM, Adrada B, Santiago L, Moseley T, Candelaria RP, Arribas E, Sun J, Leung JWT, Krishnamurthy S, Yang WT. Biopsy feasibility trial for breast cancer pathologic complete response detection after neoadjuvant chemotherapy: Imaging assessment and correlation endpoints. Ann Surg Oncol 25(7):1953-1960, 2018. e-Pub 2018. PMID: 29667115.
51. Kuerer HM, Rauch GM, Krishnamurthy S, Adrada BE, Caudle AS, DeSnyder SM, Black DM, Santiago L, Hobbs BP, Lucci A, Gilcrease M, Hwang RF, Candelaria RP, Chavez-MacGregor M, Smith BD, Arribas E, Moseley T, Teshome M, Miggins MV, Valero V, Hunt KK, Yang WT. A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy. Ann Surg 267(5):946-951, 2018. e-Pub 2018. PMID: 28549010.
52. Candelaria RP, Hansakul P, Thompson AM, Le-Petross H, Valero V, Bassett R, Huang ML, Santiago L, Adrada BE. Analysis of stereotactic biopsies performed on suspicious calcifications identified within 24 months after completion of breast conserving surgery and radiation therapy for early breast cancer: Can biopsy be obviated?. Am J Surg 215(4):693-698, 2018. e-Pub 2018. PMID: 28712671.
53. Candelaria RP, Krishnamurthy S, Huang ML, Santiago L, Adrada BE. Imaging and pathological findings in a case of invasive squamous cell carcinoma of the breast. Breast J 24(2):203-204, 2018. e-Pub 2018. PMID: 28727282.
54. Dogan BE, Scoggins ME, Son JB, Wei W, Candelaria R, Yang WT, Ma J. American College of Radiology-Compliant short protocol breast MRI for high-risk breast cancer screening: A prospective feasibility study. AJR Am J Roentgenol 210(1):1-8, 2018. e-Pub 2018. PMID: 29091003.
55. Huang ML, Hess K, Candelaria RP, Eghtedari M, Adrada BE, Sneige N, Fornage BD. Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of the literature. Eur Radiol 27(7):2928-2933, 2017. e-Pub 2017. PMID: 27844099.
56. Huang ML, Speer M, Dogan BE, Rauch GM, Candelaria RP, Adrada BE, Hess KR, Yang WT. Imaging-concordant benign MRI-guided vacuum-assisted breast biopsy may not warrant MRI follow-up. AJR Am J Roentgenol 208(4):1-7, 2017. e-Pub 2017. PMID: 28140609.
57. Candelaria RP, Bassett RL, Symmans WF, Ramineni M, Moulder SL, Kuerer HM, Thompson AM, Yang WT. Performance of mid-treatment breast ultrasound and axillary ultrasound in predicting response to neoadjuvant chemotherapy by breast cancer subtype. Oncologist 22(4):394-401, 2017. e-Pub 2017. PMID: 28314842.
58. Candelaria RP, Huang ML, Adrada BE, Bassett R, Hunt KK, Kuerer HM, Smith BD, Chavez-MacGregor M, Yang WT. Incremental cancer detection of locoregional restaging with diagnostic mammography combined with whole breast and regional nodal ultrasound in women with newly-diagnosed breast cancer. Acad Radiol 24(2):191-199, 2017. e-Pub 2017. PMID: 27955877.
59. Shin K, Caudle AS, Kuerer HM, Santiago L, Candelaria RP, Dogan B, Leung J, Krishnamurthy S, Yang W. Radiologic mapping for targeted axillary dissection: Needle biopsy to excision. AJR Am J Roentgenol 207(6):1-8, 2016. e-Pub 2016. PMID: 27726422.
60. He H, Plaxco JS, Wei W, Huo L, Candelaria RP, Kuerer HM, Yang WT. Incremental cancer detection using breast ultrasonography versus breast magnetic resonance imaging in the evaluation of newly diagnosed breast cancer patients. Br J Radiol 89(1065):20160401, 2016. e-Pub 2016. PMID: 27384241.
61. Caudle AS, Yang WT, Krishnamurthy S, Mittendorf EA, Black DM, Gilcrease MZ, Bedrosian I, Hobbs BP, DeSnyder SM, Hwang RF, Adrada BE, Shaitelman SF, Chavez-MacGregor M, Smith BD, Candelaria RP, Babiera GV, Dogan BE, Santiago L, Hunt KK, Kuerer HM. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: Implementation of targeted axillary dissection. J Clin Oncol 34(10):1072-8, 2016. e-Pub 2016. PMID: 26811528.
62. Shaitelman SF, Tereffe W, Dogan BE, Hess KR, Caudle AS, Valero V, Stauder MC, Krishnamurthy S, Candelaria RP, Strom EA, Woodward WA, Hunt KK, Buchholz TA, Whitman GJ. Role of ultrasonography of regional nodal basins in staging triple-negative breast cancer and implications for local-regional treatment. Int J Radiat Oncol Biol Phys 93(1):102-10, 2015. e-Pub 2015. PMID: 26279028.
63. Candelaria R, Fornage BD. Second-look US examination of MR-detected breast lesions. J Clin Ultrasound 39(3):115-21, 2011. e-Pub 2011. PMID: 21387324.
64. Majumdar G, Harmon A, Candelaria R, Martinez-Hernandez A, Raghow R, Solomon SS. O-glycosylation of Sp1 and transcriptional regulation of the calmodulin gene by insulin and glucagon. Am J Physiol Endocrinol Metab 285(3):E584-91, 2003. e-Pub 2003. PMID: 12900380.
65. Keembiyehetty CN, Candelaria RP, Majumdar G, Raghow R, Martinez-Hernandez A, Solomon SS. Paradoxical regulation of Sp1 transcription factor by glucagon. Endocrinology 143(4):1512-20, 2002. e-Pub 2002. PMID: 11897710.
66. Candelaria RP. Triple-negative breast cancer ultrasound tumor response patterns during neoadjuvant therapy. Breast Cancer Res Treat.

Invited Articles

1. Adrada BE, Candelaria R, Rauch GM. MRI for the staging and evaluation of response to therapy in breast cancer. Top Magn Reson Imaging 26(5):211-218, 2017. e-Pub 2017. PMID: 28961570.
2. Huang ML, Adrada BE, Candelaria R, Thames D, Dawson D, Yang WT. Stereotactic breast biopsy: Pitfalls and pearls. Tech Vasc Interv Radiol 17(1):32-39, 2014. e-Pub 2014. PMID: 24636329.
3. Candelaria RP, Hwang L, Bouchard RR, Whitman GJ. Breast ultrasound: Current concepts. Semin Ultrasound CT MR 34(3):213-25, 2013. e-Pub 2013. PMID: 23768888.

Other Articles

1. Huang ML, Tomkovich K, Lane DL, Katta R, Candelaria RP, Santiago L Breast cancer cryoablation fundamentals past and present technique optimization and imaging pearls. Acad Radiol 30(10):2383-2395, 2023. PMID: 37455177.
2. Abdelhafez AH, Musall BC, Adrada BE, Hess K, Son JB, Hwang KP, Candelaria RP, Santiago L, Whitman GJ, Le-Petross HT, Moseley TW, Arribas E, Lane DL, Scoggins ME, Leung JWT, Mahmoud HS, White JB, Ravenberg EE, Litton JK, Valero V, Wei P, Thompson AM, Moulder SL, Pagel MD, Ma J, Yang WT, Rauch GM Tumor necrosis by pretreatment breast MRI: Association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat 185(1):1-12, 2021. PMID: 32920733.
3. Santiago L, Candelaria RP, Huang ML MR imaging-guided breast interventions: Indications, key principles, and imaging-pathology correlation. Magn Reson Imaging Clin N Am 26(2):235-246, 2018. PMID: 29622128.
4. Santiago L, Adrada BE, Huang ML, Wei W, Candelaria RP Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. Breast Cancer Res Treat 166(1):29-39, 2017. PMID: 28730339.

Abstracts

1. Zhou Z, Adrada BE, Candelaria RP, Elshafeey NA, Boge M, Mohamed RM, Pashapoor S, Sun J, Xu J, Panthi B, Son JB, Guirguis M, Patel MM, Whitman G, Moseley T, Scoggins ME, White JB, Litton JK, Valero V, Hunt K, Tripathy D, Yang W, Wei P, Yam C, Pagel M, Rauch JM, Ma J. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. 2023 45th Annual International Conference of the IEEE Engineering in Medicine & Biology Conference (EMBC, 2023. e-Pub 2023.
2. Zhou Z, Adrada BE, Candelaria RP, Mohamed RM, Pashapoor S, Panthi B, Son JB, Xu Z, Hwang KP, Guirguis MS, Yang WT, Whitman GJ, Lane DL, Le-Petross HC, Leung JWT, Moseley T, Scoggins ME, Patel MM, Perez F, White J, Litton J, Valero V, Tripathy D, Yam C, Pagel MD, Ma J, Rauch GM. Deep learning using pre-treatment MRIs and clinical information for prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2022. e-Pub 2022.
3. Adrada BE, Guirguis MS, Patel MM, Perez F, Candelaria RP, Yang WT, Sun J, Mohamed RM, Boge M, Le-Petross HC, Leung JWT, Whitman GJ, Lane DL, Scoggins ME, Moseley T, Musall B, White J, Zhou Z, Wei P, Son JB, K-P H, Panthi B, Pagel M, Huo L, Hunt K, Ravenberg E, Thompson A, Litton J, Valero V, Tripathy D, Moulder S, Yam C, Ma J, Rauch GM. Development of a combined model for early prediction of pathologic complete response (pCR) in triple negative breast cancer (TNBC) undergoing neoadjuvant therapy (NAT). 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2022. e-Pub 2022.
4. Mohamed RM, Panthi B, Adrada BE, Candelaria RP, Guirguis MS, Yang WT, Boge M, Patel MM, Elshafeey NA, Pashapoor S, Zhou Z, Son JB, K-P H, Le-Petross HC, Leung JWT, Scoggins ME, Whitman GJ, Xu Z, Lane DL, Moseley TW, Perez F, White J, Chen H, Sun J, Wei P, Litton J, Valero V, Tripathy D, Yam C, Pagel MD, Ma J, Rauch GM. Multi-parametric MRI-based radiomics models for early neoadjuvant systemic treatment response prediction in triple negative breast cancer (TNBC). 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2022. e-Pub 2022.
5. Nia E, Bassett R, Patel M, Kapoor M, Perez F, Guirguis M, Candelaria R. Comparing the performance of full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) in the post-treatment surveillance of patients with a history of breast cancer: A retrospective study. 108th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2022. e-Pub 2022.
6. Candelaria RP, Bassett R, Boge M, Patel M, Lane DL, Adrada BE, Guirguis MS, Le-Petross H, Leung JW, Perez F, Santiago L, Scoggins ME, Spak DA, Whitman GJ, Rauch GM, Yang WT. Immunogenic response and abnormal axillary node morphology in triple negative breast cancer patients. 107th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2021. e-Pub 2021.
7. Candelaria RP, Hess K, Lane DL, Santiago L, Moulder S, Yang WT, Thompson A, Rauch GM, Huang ML, Arribas EM, Scoggins ME, Moseley TW, Le-Petross HC, Spak DA, Whitman GJ, Leung JW, Valero V, Damodaran S, Litton J, White J, Adrada BE. Predicting pathologic complete response with ultrasound tumor characteristics in triple negative breast cancer patients. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2019. e-Pub 2019.
8. Strigel RM, Candelaria RP, Johnston B, Kohr JR, Lam DL, Maimone IV S, Mercado CL, Porembka JH, Rauch GM, Reiner JS, Verma R, Woods RW, Niell BL, Reig B, Narayan AK, Yeh ED, Bennett DL, Ataya D, Ha RS, Neuschler EI, Thigpen DM. MR imaging-guided breast biopsy. 105th Annual Meeting and Scientific Assembly of the Radiological Society of North America Program, 2019. e-Pub 2019.
9. Candelaria RP, Adrada BE, Santiago L, Lane DL, Wei W, Yang WT, Huang ML, Arribas EM, Rauch GM, Thompson A, Moulder S. Can mid-treatment ultrasound in triple negative breast cancer patients predict residual pathologic disease in the axillary nodes?. 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2018. e-Pub 2018.
10. Candelaria RP, Adrada BE, Santiago L, Lane DL, Wei W, Yang WT, Huang ML, Arribas EM, Rauch GM, Thompson A, Moulder S. Do triple negative breast cancers have characteristic imaging features according to androgen receptor and vimentin status?. 104th Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2018. e-Pub 2018.
11. Yam C, Huo L, Hess KR, Litton JK, Yang W, Piwnica-Worms H, Mittendorf EA, Ueno NT, Lim B, Murthy RK, Damodaran S, Helgason T, Thompson AM, Santiago L, Candelaria RP, Rauch GM, Adrada BE, Symmans WF, Gilcrease MZ, Moulder SL. Androgen receptor positivity is associated with nodal disease in triple negative breast cancer. Cancer Res, 2018. e-Pub 2018.
12. Rauch GM, Zhu H, Li H, Adrada BE, Santiago L, Candelaria RP, Wang H, Leung J, Litton J, Wu Y, Murthy R, Mittendorf EA, Yang W. Association of quantitative MRI features with tumor infiltrating lymphocytes and treatment response prediction in HER2 positive subtype of breast cancer. Cancer Res, 2018. e-Pub 2018.
13. Echeverria GV, Cai S, Tu Y, McCoy A, Lau R, Redwood A, Rauch G, Adrada B, Candelaria R, Santiago L, Thompson A, Litton J, Moulder S, Symmans F, Chang JT, Piwnica-Worms H. A molecularly annotated collection of breast cancer patient-derived xenograft models aligned with ongoing clinical trials built from fine needle aspiration samples throughout neoadjuvant treatment. Cancer Res, 2018. e-Pub 2018.
14. Rauch GM, Adrada BE, Kappadath SC, Candelaria RP, Santiago L, Yang WT, Moseley TW, Huang ML, Scoggins ME, Knudtson JD, Lopez B, Hess K, Krishnamurthy S, Moulder S, Valero V. Prediction of tumor response to neoadjuvant chemotherapy in breast cancer patients using quantitative Tc99m Sestamibi molecular breast imaging: Preliminary results. 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2017. e-Pub 2017.
15. Moon HJ, Caudle AS, Kuerer HM, Adrada BE, Candelaria RP, Yang WT, Santiago L, Krishnamurthy S, Wei W. Targeted axillary dissection: Challenges with axillary lymph node clip placement, clip identification, and clip retrieval post neoadjuvant therapy. 103rd Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2017. e-Pub 2017.
16. Lane DL, Santiago L, Candelaria RP, Scoggins ME, Rauch GM, Adrada BE, Huang ML, Geiser WR, Hess K. Synthesized mammography (SM) versus full field digital mammography (FFDM): A comparison of lesion detection by radiologists. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2016. e-Pub 2016.
17. Hansakul P, Candelaria RP, Le-Petross HC, Huang ML, Santiago L, Adrada BE. Analysis of stereotactic biopsies performed on calcifications identified after recent completion of breast conserving therapy: Can biopsy be obviated?. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2016. e-Pub 2016.
18. Santiago L, Adrada BE, Huang ML, Candelaria RP. Neoplastic seeding in the setting of percutaneous image guided breast biopsies. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2016. e-Pub 2016.
19. Candelaria RP, Geiser WR, Huang ML, Jr BR, Lane DL, Santiago L, Scoggins ME, Arribas EM, Adrada BE. Computer-aided detection (CAD) for synthesized mammography: Does it perform the same as CAD for full-field digital mammography?. 102nd Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2016. e-Pub 2016.
20. Omofoye T, Candelaria RP, Wei W, Dogan B, Nguyen X, Kuerer HM, Yang WT. Development of an ultrasound (US) lexicon to improve detection of axillary lymph node (AXLN) metastasis in patients with primary breast cancer. Society of Breast Imaging Symposium Program, 2016. e-Pub 2016.
21. Plaxo JS, He H, Huo L, Wei W, Candelaria RP, Yang WT, Kuerer HM. Incremental cancer detection utilizing breast ultrasound versus breast MRI in the evaluation of newly diagnosed breast cancer patients. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
22. Candelaria RP, Adrada BE, Huang ML, Santiago L, Nguyen X, Fornage BD. Not just shades of grey - A review of the ACR BI-RADS ultrasound lexicon. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
23. Adrada BE, Huang ML, Candelaria RP, Santiago L, Rauch GM, Arribas EM, Dawson D, Albarracin C, Moseley TW, Whitman GJ. Intraoperative specimen radiography - Going beyond the block. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America, 2015. e-Pub 2015.
24. Rauch GM, Adrada BE, Huang ML, Candelaria RP, Arribas EM, Yang WT, Cox K, Santiago L, Kappadath SC. Molecular breast imaging: An adjunct diagnostic modality for breast cancer evaluation. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
25. Candelaria RP, Huang ML, Adrada BE, Arribas EM, Scoggins ME, Yang WT, Schopp JG, Dryden MJ, Le-Petross HC, Moseley TW, Whitman GJ, Rauch GM, Santiago L. Comparing the performance of full-field digital mammography (FFDM), digital breast tomosynthesis (DBT) and whole breast ultrasound (WBUS) in the initial staging evaluation of breast cancer: Interim results of a prospective study. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
26. Santiago L, Candelaria RP, Arribas EM, Huang ML, Scoggins ME, Adrada BE, Rauch GM, Thames D, Whitman GJ. Noncalcified ductal carcinoma in situ: The danger that lies beneath. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
27. Huang ML, Speer ME, Dogan BE, Rauch GM, Candelaria RP, Yang WT, Hess K, Adrada BE. Following imaging-concordant benign MRI-guided vacuum-assisted breast biopsy: Is MRI follow up needed. 101st Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2015. e-Pub 2015.
28. Huang ML, Hess K, Candelaria RP, Eghtedari M, Adrada BE, Sneige N, Fornage BD. Comparison of the accuracy of US-guided biopsy of breast masses performed with 18-gauge, 16-gauge and 14-gauge automated cutting needle biopsy devices. European Congress of Radiology Program, 2015. e-Pub 2015.
29. Caudle AS, Yang WT, Mittendorf EA, Black DM, Gilcrease M, Bedrosian I, Hobbs BP, Candelaria RP, Babiera GV, Dogan DE, Lim MJ, Santiago L, Hunt KK, Krishnamurthy S, Kuerer HM. Targeted axillary dissection improves axillary evaluation following neoadjuvant chemotherapy in node positive breast cancer. Society of Surgical Oncology Annual Cancer Symposium, 2015. e-Pub 2015.
30. Candelaria RP, Huang ML, Adrada BE, Yang WT. Relevance of additional mammography and ultrasonography for newly diagnosed breast cancer patients (BI-RADS 6). 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2014. e-Pub 2014.
31. Candelaria RP, Symmans WF, Ramineni M, Yang WT. Ultrasound predicts residual disease in triple negative and ER+ breast cancer but not in HER2+ breast cancer. 100th Scientific Assembly and Annual Meeting of the Radiological Society of North America Program, 2014. e-Pub 2014.
32. Majumdar G, Candelaria R, Solomon S. Glycosylation: A critical regulatory step in insulin activation of Sp1 transcription factor. Diabetes 51(2):A574, 2002. e-Pub 2002.
33. Candelaria R, Keembiyehetty C, Majumdar G, Martinez A, Raghow R, Solomon S. Glucagon regulates Sp1 transcription factor in liver cells. J Investig Med 50(1):142A (#743), 2002. e-Pub 2002.

Book Chapters

1. Lane D, Candelaria R, Fornage BD. Sonography of the breast. In: Manual SOGIMIG de Ultrassonografia em Ginecologia e Obstetricia. Medbook, 373-380, 2018.
2. Candelaria R. Fat-containing mass. In: Diagnostic Imaging: Breast. 2nd Edition. Amirsys, Inc, 4.14-4.19, 2013.
3. Candelaria R, Yang WT. Posterior shadowing (US). In: Diagnostic Imaging: Breast. 2nd Edition. Amirsys, Inc, 4.202-4.207, 2013.
4. Candelaria R. High-density mass. In: Diagnostic Imaging: Breast. 2nd Edition. Amirsys, Inc, 4.42-4.45, 2013.
5. Candelaria R, Yang WT. Posterior enhancement (US). In: Diagnostic Imaging: Breast. 2nd Edition. Amirsys, Inc, 4.196-4.201, 2013.